Malden, MA, United States of America

Alex Mugwiria Muthengi

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Mugwiria Muthengi. Retrieved from https://idiyas.com/inventor/alex-mugwiria-muthengi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Alex Mugwiria Muthengi

Introduction

Alex Mugwiria Muthengi is an accomplished inventor based in Malden, Massachusetts. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on the treatment and diagnosis of various diseases and disorders.

Latest Patents

Muthengi holds a patent for "Certain imidazopyridines as cyclic AMP response element binding (CREB) binding protein (CBP) inhibitors and uses thereof." This patent relates to compounds that act as CBP inhibitors and outlines methods for using these compounds in medical applications. His innovative approach has the potential to impact therapeutic strategies significantly.

Career Highlights

Muthengi is affiliated with the University of Massachusetts, where he conducts research and collaborates with other scientists. His work has been recognized for its potential to advance the understanding of disease mechanisms and improve treatment options.

Collaborations

Muthengi has worked alongside notable colleagues such as Wei Zhang and Hailemichael O Yosief. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Alex Mugwiria Muthengi is a notable inventor whose work in developing CBP inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches to treat complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…